ABOUT this BLOG and How to use it

WELCOME to Stu's Views & MS News. A product of MS Views and News, a Not-for-Profit [501c3] organization. Founded in 2008, we provide educational Multiple Sclerosis information via live seminars and via the internet.

Key-Notes: Our live seminars average approx 60 people per educational program. Our blog is visited over 2900 times per week and our website is visited by thousands each month.

Register at our website to receive our globally transmitted Multiple Sclerosis e-newsletter, currently being received in (90) Countries.

On this blog see our Directory, Archives, recent Blog Posts & so much more. Use the Blog Search box (enter a keyword). See our Facebook information AND Links to other MS Organizations & bloggers. Scroll through entire page, to find information that could EMPOWER You. At the Bottom of this page, see informational videos and some for fun.

Disclaimer: "Stu's Views & MS News" / 'MS Views and News' does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Like this blog? - CLICK "LIKE"

Thursday, September 30, 2010

FP88 Vaccine for Multiple Sclerosis and Other Autoimmune Diseases

Thanks to Marc F., in Ft. Lauderdale, we have this to blog about:


East Carolina University seeks a collaborative partner to develop a new advancement in the treatment and prevention of autoimmune diseases—especially multiple sclerosis (MS).

MS afflicts more than 2.5 million people worldwide. In the United States alone, 400,000 people suffer from the disorder at an annual cost to the economy of about $20 billion. MS is an autoimmune disease that affects the central nervous system, and more particularly, the myelin material that surrounds and protects individual nerve fibers. The body’s own immune system attacks the myelin, leaving behind lesions and scarring that interrupt electric impulses traveling to and from the brain. Symptoms of MS include fatigue, bladder and bowel dysfunction, difficulty in walking, reduced cognitive function, dizziness, depression, pain, visual impairment, sexual dysfunction, and other symptoms. No cure exists for MS, but various treatments are available to improve the quality of life for those living with the disease. The global market for these treatments is currently estimated at $4.9 billion.

READ MORE, by clicking here


***********************************************************
"Providing You with 'MS Views and News'is what we do"
Keep Informed and up-to-date with information concerning
 Multiple Sclerosis when registered at
****************************************************************
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
****************************************************************

1 comments:

Briana said...

Tantalizing news story. But now what? I can't find any more information. Did they get any investors/funding? Is someone else taking up the the research? It looks very promising. As did the one done in Portlans, OR. That was a couple years ago and I don't see anything recent on that one either.